Hemrajani Rekha's Form 4/A amendment
AmendedBioAge Labs, Inc. (BIOA) · filed Mar 10, 2025
- Accession no.
- 0001415889-25-007506
- Filed
- Mar 10, 2025
- Trade date
- Apr 17-Sep 27, 2024
- Filing delay
- 327 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Sep 27, 2024
This filing lists 1 non-derivative transaction and 2 derivative transactions. Open-market purchases total $54.0K. It was filed 327 days after the trade.
This amendment replaces 0001415889-24-024043 (filed Sep 27, 2024).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hemrajani RekhaCIK 0001771213 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2024 | Common Stock | PPurchaseAcquired | +3,000 | $18.00 | +$54,000 | 3,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2024 | Common Stock | AGrant or awardAcquired | +15,000 | $0.00 | $0 | 15,000 | Direct | |
| Apr 17, 2024 | Common Stock | AGrant or awardAcquired | +28,497 | $0.00 | $0 | 28,497 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.